Literature DB >> 29970978

General Anesthesia With Dexmedetomidine and Remifentanil in a Neonate During Oracotomy and Resection of a Congenital Cystic Adenomatoid Malformation.

Ellise Cappuccio, Arlyne K Thung, Joseph D Tobias.   

Abstract

Based on animal data, concern has been expressed regarding the potential deleterious neurocognitive effects of general anesthesia during infancy and early life. Although there are no definitive data to prove this effect, the neonatal period has been suggested to be the most vulnerable period. While various inhaled and intravenous anesthetic agents have been implicated, dexmedetomidine and the opioids may be devoid of such effects. However, there are limited data regarding the combination of these agents during neonatal surgery and anesthesia. We present the use of these agents in combination with epidural anesthesia for postoperative analgesia in a 1-day-old neonate during thoracotomy and excision of a congental cystic adenomatoid malformation. Previous reports of the use of this unique combination of agents are reviewed and their role in this scenario discussed.

Entities:  

Keywords:  anesthesia; dexmedetomidine; neurotoxicity; pediatric anesthesia; remifentanil

Year:  2018        PMID: 29970978      PMCID: PMC6027977          DOI: 10.5863/1551-6776-23.3.215

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  19 in total

1.  Anesthetists rather than anesthetics are the threat to baby brains.

Authors:  Markus Weiss; Bruno Bissonnette; Thomas Engelhardt; Sulpicio Soriano
Journal:  Paediatr Anaesth       Date:  2013-10       Impact factor: 2.556

Review 2.  Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology.

Authors:  Joseph D Tobias
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

3.  Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood.

Authors:  Lena S Sun; Guohua Li; Tonya L K Miller; Cynthia Salorio; Mary W Byrne; David C Bellinger; Caleb Ing; Raymond Park; Jerilynn Radcliffe; Stephen R Hays; Charles J DiMaggio; Timothy J Cooper; Virginia Rauh; Lynne G Maxwell; Ahrim Youn; Francis X McGowan
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

4.  Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.

Authors:  A K Ross; P J Davis; G L Dear Gd; B Ginsberg; F X McGowan; R D Stiller; L G Henson; C Huffman; K T Muir
Journal:  Anesth Analg       Date:  2001-12       Impact factor: 5.108

Review 5.  Use of anesthetic agents in neonates and young children.

Authors:  R Daniel Mellon; Arthur F Simone; Bob A Rappaport
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

Review 6.  Remifentanil for general anaesthesia: a systematic review.

Authors:  R Komatsu; A M Turan; M Orhan-Sungur; J McGuire; O C Radke; C C Apfel
Journal:  Anaesthesia       Date:  2007-12       Impact factor: 6.955

7.  Dexmedetomidine pretreatment attenuates propofol‑induced neurotoxicity in neuronal cultures from the rat hippocampus.

Authors:  Yi Wei; Junhua Hu; Yubing Liang; Yuling Zhong; Dan He; Yi Qin; Li Li; Jing Chen; Qiang Xiao; Yubo Xie
Journal:  Mol Med Rep       Date:  2016-08-12       Impact factor: 2.952

8.  Dexmedetomidine attenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat.

Authors:  Xiaoning Wang; Binjiang Zhao; Xue Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function.

Authors:  Andreas W Loepke; Sulpicio G Soriano
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

10.  Non-Trigger Anesthesia Management in a Patient With Leigh's Syndrome Presenting for Dental Rehabilitation.

Authors:  M-Irfan Suleman; Thejovathi Edala; Edwin Abraham; M-Saif Siddiqu
Journal:  Anesth Pain Med       Date:  2015-11-30
View more
  1 in total

1.  Dexmedetomidine attenuates haemorrhage-induced thalamic pain by inhibiting the TLR4/NF-κB/ERK1/2 pathway in mice.

Authors:  Tianfeng Huang; Yong Li; Wenqing Hu; Dapeng Yu; Ju Gao; Fan Yang; Yingying Xu; Zehua Wang; Liang Zong
Journal:  Inflammopharmacology       Date:  2021-10-13       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.